Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Blue Trust Inc.

Blue Trust Inc. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,747 shares of the medical equipment provider’s stock after buying an additional 1,014 shares during the quarter. Blue Trust Inc.’s holdings in Intuitive Surgical were worth $2,332,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. AQR Capital Management LLC boosted its position in Intuitive Surgical by 12.6% in the 2nd quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock worth $18,958,000 after purchasing an additional 4,775 shares in the last quarter. Creative Planning boosted its holdings in Intuitive Surgical by 9.8% during the second quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock worth $28,043,000 after buying an additional 5,629 shares in the last quarter. NewEdge Advisors LLC grew its position in Intuitive Surgical by 8.2% during the second quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock valued at $6,150,000 after buying an additional 1,044 shares during the period. Northwestern Mutual Wealth Management Co. increased its holdings in Intuitive Surgical by 2.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock valued at $9,100,000 after buying an additional 411 shares in the last quarter. Finally, Wellington Wealth Strategies LLC. purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $241,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 1.8 %

Shares of NASDAQ ISRG opened at $573.48 on Tuesday. The business’s 50 day moving average is $547.16 and its two-hundred day moving average is $505.21. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market cap of $204.26 billion, a price-to-earnings ratio of 92.20, a PEG ratio of 5.19 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 42,265 shares of company stock worth $21,964,281. 0.90% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. Mizuho lifted their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Wells Fargo & Company upped their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday. Barclays lifted their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday. Citigroup upped their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday. Finally, Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.